FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Pfizer Caduet Recall

Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/20 mg*, 30-count bottl…

Pfizer Inc. · New York, NY

Risk level
Class II
Reported by FDA
Feb 19, 2020
Recall ID
D-0841-2020
Check your lot numberHow we source this data

Summary

Pfizer recalled Caduet starting Feb 5, 2020. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0841-2020 on Feb 19, 2020. Reason: Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection. Status: Terminated.

Why it was recalled

Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.

Product description

Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/20 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2180-30.

Lot numbers, UPCs & expiration codes

Lot #: CY0937, Exp 12/2021

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0841-2020
Classification
Class II
Status
Terminated
Recall initiated
Feb 5, 2020
FDA report date
Feb 19, 2020
Quantity
141 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Pfizer Inc.

Original FDA data

Every field from FDA enforcement report D-0841-2020, exactly as published.

Show all FDA fields
City
New York
State
NY
Status
Terminated
Country
United States
Event ID
84860
Address
235 E 42nd St
Code information
Lot #: CY0937, Exp 12/2021
Postal code
10017-5703
Report date
Feb 19, 2020
Product type
Drugs
Recall number
D-0841-2020
Classification
Class II
Recalling firm
Pfizer Inc.
Product quantity
141 bottles
Termination date
Mar 8, 2021
Reason for recall
Defective Container: products potentially could have been packaged in defective bottles, with a notched rim, that could cause inadequate foil sealing resulting in lack of moisture protection.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Caduet (amlodipine besylate/atorvastatin calcium) Tablets, 10 mg/20 mg*, 30-count bottle, Rx only, Distributed by: Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Germany, NDC 0069-2180-30.
Distribution pattern
Nationwide in the USA.
Recall initiation date
Feb 5, 2020
Initial firm notification
Letter
Center classification date
Feb 13, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0841-2020, published Feb 19, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls